Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients.

Hepatocellular carcinoma (HCC) is a common lethal disease in Asia and there is no effective chemotherapy. Identification of new effective drugs in the treatment of inoperable HCC is urgently need. This is a phase II clinical study to investigate the efficacy, toxicity and pharmacokinetics of paclita...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Y., Chan, W. K., Birkhofer, M. J., Hu, O. Y., Wang, S. S., Huang, Y. S., Liu, M., Whang-Peng, J., Chi, K. H., Lui, W. Y., Lee, S. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062942/
https://www.ncbi.nlm.nih.gov/pubmed/9662247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062942/
https://www.ncbi.nlm.nih.gov/pubmed/9662247

Ejemplares similares